4.7 Article

A new rhodium(I) NHC complex inhibits TrxR: In vitro cytotoxicity and in vivo hepatocellular carcinoma suppression

期刊

出版社

ELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER
DOI: 10.1016/j.ejmech.2019.111721

关键词

Rhodium(I) NHC complexs; Thioredoxin reductase; Apoptosis; Reactive oxygen species; Hepatocellular carcinoma

资金

  1. National Natural Science Foundation of China [81703337]
  2. Jiangsu Specially-Appointed Professors program
  3. Open Project of State Key Laboratory of Natural Medicines [SKLNMKF201808, SKLNMKF201712]
  4. State Key Laboratory of Coordination Chemistry, Nanjing University
  5. Six Talent Peaks Project in Jiangsu Province of China [SWYY-069]

向作者/读者索取更多资源

Thioredoxin reductase (TrxR) is often overexpressed in different types of cancer cells including hepatocellular carcinoma (HCC) cells and regarded as a target with great promise for anticancer drug research and development. Here, we have synthesized and characterized nine new designed rhodium(I) N-heterocyclic carbene (NHC) complexes. All of them were effective towards cancer cells, especially complex le was more active than cisplatin and manifested strong antiproliferative activity against HCC cells. In vivo anticancer studies showed that le significantly repressed tumor growth in an HCC nude mouse model and ameliorated liver lesions in a chronic HCC model caused by CCl4. Notably, a mechanistic study revealed that le can strongly inhibit TrxR system both in vitro and in vivo. Furthermore, le promoted intracellular ROS accumulation, damaged mitochondrial membrane potential, promoted cancer cell apoptosis and blocked the cells in the Cl phase. (C) 2019 Elsevier Masson SAS. All rights reserved.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Review Chemistry, Medicinal

Pt(II) and Au(III) complexes containing Schiff-base ligands: A promising source for antitumor treatment

Ying Sun, Yunlong Lu, Mianli Bian, Zhibin Yang, Xiaoyan Ma, Wukun Liu

Summary: The Pt(II) and Au(III) Schiff-base complexes as potential antitumor agents have shown remarkable biological activities and good stability. They act through different mechanisms, providing a feasible solution for improving the side effects of metal chemotherapy.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2021)

Review Chemistry, Inorganic & Nuclear

An overview of anticancer platinum N-heterocyclic carbene complexes

Sai Zhao, Zhibing Yang, Guizhi Jiang, Sheng Huang, Mianli Bian, Yunlong Lu, Wukun Liu

Summary: NHCs have been introduced as a new platform for the development of anticancer metal complexes, with platinum NHC complexes showing comparable activities to cisplatin and exhibiting different mechanisms of action, including the induction of biochemical hallmarks of immunogenic cell death (ICD) as a type II ICD inducer. These features make them promising candidates in the field of anticancer research.

COORDINATION CHEMISTRY REVIEWS (2021)

Review Pharmacology & Pharmacy

Repurposing of the gold drug auranofin and a review of its derivatives as antibacterial therapeutics

Yuanhao Liu, Yunlong Lu, Zhongren Xu, Xiaoyan Ma, Xiuli Chen, Wukun Liu

Summary: Multidrug resistance is a significant issue in antibiotic clinical application, leading researchers to explore the potential of auranofin and other gold complexes as antibacterial agents. These advances offer a new perspective on the treatment of bacterial infections.

DRUG DISCOVERY TODAY (2022)

Article Chemistry, Medicinal

Pt(II)-NHC Complex Induces ROS-ERS-Related DAMP Balance to Harness Immunogenic Cell Death in Hepatocellular Carcinoma

Mianli Bian, Rong Fan, Zhibin Yang, Yanan Chen, Zhongren Xu, Yunlong Lu, Wukun Liu

Summary: The research introduces a new Pt(II)-NHC complex termed 2c, which exhibits potent anticancer activities in HCC cells and can induce cell death, potentially activating genes. The study suggests that 2c is a type II ICD inducer, capable of inducing cell death in HCC cells by causing endoplasmic reticulum stress and generating reactive oxygen species.

JOURNAL OF MEDICINAL CHEMISTRY (2022)

Editorial Material Chemistry, Multidisciplinary

Editorial: Frontiers in Chemistry-Rising Stars: Asia

Lei Guo, Jyotirmayee Mohanty, Wukun Liu, Taner Yonar, Hongyan Sun, Tsuyoshi Minami, Jafar Soleymani, Basem Moosa, Qianxiong Zhou

FRONTIERS IN CHEMISTRY (2021)

Article Chemistry, Medicinal

Heteroleptic Gold(I)-bisNHC complex with excellent activity in vitro, ex vivo and in vivo against endometrial cancer

Qimeng Xiao, Yuanhao Liu, Guizhi Jiang, Yuan Liu, Yan Huang, Wukun Liu, Zhenbo Zhang

Summary: In this study, a novel gold compound (Complex 10) was designed and synthesized, which showed strong anti-EC activity and outperformed the existing drug auranofin in cell, organoid, and xenograft models. Mechanistically, Complex 10 suppressed the expression of key proteins involved in EC development. These findings suggest the potential of Complex 10 as a treatment option for EC.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2022)

Article Chemistry, Medicinal

Novel phosphanegold(I) thiolate complexes suppress de novo lipid synthesis in human lung cancer

Miao Luo, Xiaoyan Ma, Weiling Jiang, Jun Zhang, Wukun Liu, Shuang Wei, Huiguo Liu

Summary: The upregulation of lipid metabolism is a common characteristic change in tumor cells. This study investigated the effects of phosphanegold(I) thiolate complexes on the regulation of lipid metabolism in lung cancer cells. The complexes inhibited lung cancer cell growth, impaired mitochondrial structure and function, reduced endogenous fatty acid and phospholipid synthesis, and induced apoptosis in lung cancer cells.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2022)

Article Biochemistry & Molecular Biology

Mecheliolide elicits ROS-mediated ERS driven immunogenic cell death in hepatocellular carcinoma

Zhongren Xu, Jianqiang Xu, Shibo Sun, Wei Lin, Yongming Li, Qiuyue Lu, Fuwei Li, Zhibin Yang, Yunlong Lu, Wukun Liu

Summary: Immunogenic cell death (ICD) is an immunostimulatory form of cell death that can reengage the tumor-specific immune system. This study identified micheliolide as a potential ICD inducer and showed that its effects were mediated by the generation of reactive oxygen species (ROS) and endoplasmic reticulum stress (ERS).

REDOX BIOLOGY (2022)

Article Biochemistry & Molecular Biology

Gold(I) selenium N-heterocyclic carbene complexes as potent antibacterial agents against multidrug-resistant gram-negative bacteria via inhibiting thioredoxin reductase

Xiuli Chen, Shibo Sun, Sheng Huang, Han Yang, Qing Ye, Lin Lv, Yanshan Liang, Jinjun Shan, Jianqiang Xu, Wukun Liu, Tonghui Ma

Summary: Gold(I) selenium N-heterocyclic carbene complexes H7 and H8 exhibit stronger antibacterial effects against multidrug-resistant Gram-negative bacteria by irreversibly inhibiting the activity of TrxR and inducing oxidative stress. In vivo experiments demonstrate that H7 and H8 have better antibacterial activity than auranofin, and can promote wound healing and prolong the survival time of patients with Carbapenem-resistant Acinetobacter baumannii induced peritonitis.

REDOX BIOLOGY (2023)

Article Chemistry, Multidisciplinary

NHC-gold(I)-alkyne complexes induced hepatocellular carcinoma cell death through bioorthogonal activation by palladium complex in living system

Yunlong Lu, Yuanhao Liu, Zhenlin Liang, Xiaoyan Ma, Lijuan Liu, Zhenfan Wen, Iogann Tolbatov, Alessandro Marrone, Wukun Liu

Summary: In this study, a bioorthogonal catalyst, Pd(PPh3)2Cl2, was used to convert the stable N-heterocyclic carbene (NHC)-gold(I)-alkyne complex 5 to its active species in biological environments. The active species effectively inhibits thioredoxin reductase (TrxR) and exhibits significant anticancer bioactivity in hepatocellular carcinoma (HCC).

CHINESE CHEMICAL LETTERS (2023)

Article Chemistry, Medicinal

Design, synthesis and biological evaluation of fluorinated selective estrogen receptor degraders (FSERDs) --- A promising strategy for advanced ER positive breast cancer

Yunlong Lu, Chao Liu, Xin Wang, Lijuan Liu, Zhihao Zhao, Zhenlin Liang, Yuanhao Liu, Zhenfan Wen, Qianming Du, Wukun Liu

Summary: Although endocrine therapies have shown good responses in ER+ breast cancer patients, drug resistance remains an issue. Researchers developed a new class of orally bioavailable fluorine-substituted SERDs, one of which (27b) shows excellent pharmacokinetic profiles and potential as an orally available SERD for clinical use.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2023)

Article Chemistry, Medicinal

NSAID-Au(I) Complexes Induce ROS-Driven DAMPs and Interpose Inflammation to Stimulate the Immune Response against Ovarian Cancer

Zhongren Xu, Qiuyue Lu, Min Shan, Guizhi Jiang, Yuanhao Liu, Zhibin Yang, Yunlong Lu, Wukun Liu

Summary: Inflammation promotes ovarian cancer development, and chemoresistance is a major challenge in its treatment. A series of gold(I) complexes derived from NSAIDs were synthesized, and complex B3 (Npx-Au) exhibited higher antitumor activity than cisplatin and other gold(I) complexes. Npx-Au induced oxidative stress and the DAMPs process by inhibiting TrxR activity. Mechanistic studies showed simultaneous downregulation of COX-2 and PD-L1 after Npx-Au treatment. Interestingly, in vivo experiments demonstrated that Npx-Au treatment stimulated immune response by reducing PD-L1 expression, inducing DC maturation, and increasing T cell infiltration. Overall, Npx-Au elicited immunogenic cell death and showed promise as a strategy for chemotherapy combined with immunotherapy in treating ovarian cancer.

JOURNAL OF MEDICINAL CHEMISTRY (2023)

Article Chemistry, Medicinal

Research Progress on Bioactive Metal Complexes against ER- Positive Advanced Breast Cancer

Zhenlin Liang, Lijuan Liu, Yanyu Zhou, Wukun Liu, Yunlong Lu

Summary: Breast cancer, the most prevalent cancer in women, has been treated with endocrine therapy drugs, such as tamoxifen, since 1977. However, drug resistance and side effects remain challenges in the treatment of ER+ breast cancer. Metal complexes, particularly platinum complexes, have shown promising antitumor activities and may provide new opportunities for the treatment of ER+ breast cancer.

JOURNAL OF MEDICINAL CHEMISTRY (2023)

Article Chemistry, Medicinal

Tumor-Targeting NHC-Au(I) Complex Induces Immunogenic Cell Death in Hepatocellular Carcinoma

Zhibin Yang, Mianli Bian, Lin Lv, Xingyu Chang, Zhenfan Wen, Fuwei Li, Yunlong Lu, Wukun Liu

Summary: In this study, a series of novel NHC-Au(I) complexes derived from 4,5-diarylimidazole and glycyr-rhetinic acid (GA) were designed and synthesized. Among them, complex 4C exhibited excellent tumor targeting and antitumor activity, inducing immunogenic cell death (ICD) in hepatocellular carcinoma (HCC) cells. Furthermore, 4C effectively inhibited TrxR enzyme activity, increased reactive oxygen species (ROS) expression, disrupted redox homeostasis, caused mitochondrial dysfunction and endoplasmic reticulum stress (ERS), and led to the release of damage-associated molecular patterns (DAMPs) in HCC cells. Importantly, 4C showed a strong ICD-inducing effect in a vaccination mouse model and activated antitumor immunity in a tumor-bearing C57BL/6 mouse model, consistent with the in vitro results. In conclusion, Au(I) complexes with HCC-targeted capability have the potential for effective tumor immunotherapy.

JOURNAL OF MEDICINAL CHEMISTRY (2023)

Review Chemistry, Multidisciplinary

Recent development of gold(i) and gold(iii) complexes as therapeutic agents for cancer diseases

Yunlong Lu, Xiaoyan Ma, Xingyu Chang, Zhenlin Liang, Lin Lv, Min Shan, Qiuyue Lu, Zhenfan Wen, Ronald Gust, Wukun Liu

Summary: Metal complexes, particularly gold complexes, have shown significant antitumor activities and potential as alternative chemotherapy agents due to their different mechanism of action and ability to induce immunogenic cell death. This review comprehensively summarizes the recent progress and mechanism of action of gold (I) and gold (III) complexes.

CHEMICAL SOCIETY REVIEWS (2022)

Article Chemistry, Medicinal

Highly potent dual-targeting angiotensin-converting enzyme 2 (ACE2) and Neuropilin-1 (NRP1) peptides: A promising broad-spectrum therapeutic strategy against SARS-CoV-2 infection

Shuang Mei, Su Jiang, Yuting Wang, Han Jing, Peng Yang, Miao-Miao Niu, Jindong Li, Kai Yuan, Yan Zhang

Summary: This study identifies a dual-targeting peptide, AP-1, that effectively inhibits variants of concern (VOCs) of SARS-CoV-2 without impairing host cell viability. The findings suggest that AP-1 could be a promising broad-spectrum agent for treating emerging VOCs of SARS-CoV-2.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2024)

Article Chemistry, Medicinal

Discovery of proteolysis-targeting chimera targeting undruggable proteins using a covalent ligand screening approach

Hyeonjun Lee, Ju Yeon Lee, Hyunsoo Jang, Hye Young Cho, Minhee Kang, Sang Hyun Bae, Suin Kim, Eunji Kim, Jaebong Jang, Jin Young Kim, Young Ho Jeon

Summary: By using liquid chromatography-tandem mass spectrometry and nuclear magnetic resonance experiments, we identified new chemical moieties that bind to the target sites of the protein of interest, allowing for reversible binding and protein degradation. This method has the potential to expand the application of PROTAC technology.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2024)

Article Chemistry, Medicinal

A pro-death autophagy-based nanoplatform for enhancing antitumour efficacy with improved immune responses

Yingying Li, Xiyou Du, Xinru Kong, Yuelin Fang, Zhijing He, Dongzhu Liu, Hang Wu, Jianbo Ji, Xiaoye Yang, Lei Ye, Guangxi Zhai

Summary: This study proposes a novel nanoplatform based on the autophagy cascade to overcome the obstacles in chemo-immunotherapy. The platform combines chemotherapy and starvation therapy to initiate pro-death autophagy and enhance antigen presentation, while also remodeling the immunosuppressive tumor microenvironment. Furthermore, the study discovers a new therapeutic direction for the respiration inhibitor 3-bromopyruvic acid (3BP) in cancer treatment. Overall, this study offers an opportunity to improve antitumor efficacy and boost immune responses.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2024)

Article Chemistry, Medicinal

A novel scaffold long-acting selective estrogen receptor antagonist and degrader with superior preclinical profile against ER plus breast cancer

Bingsi Wang, Mingxu Ma, Yusen Dai, Pengfei Yu, Liang Ye, Wenyan Wang, Chunjie Sha, Huijie Yang, Yingjie Yang, Yunjing Zhu, Lin Dong, Shujuan Wei, Linlin Wang, Jingwei Tian, Hongbo Wang

Summary: Breast cancer is a common malignant tumor in women, and drug resistance remains a clinical challenge. In this study, a novel compound, G-5b, was developed with potent antagonistic and degradation activities comparable to the current drug fulvestrant. G-5b also showed improved stability and solubility. Mechanistically, G-5b engages the proteasome pathway to degrade ER, inhibiting the ER signaling pathway and inducing apoptosis and cell cycle arrest. In animal models, G-5b exhibited superior pharmacokinetics and pharmacodynamics properties. Overall, G-5b is a promising long-acting SERD worthy of further investigation and optimization.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2024)

Article Chemistry, Medicinal

HDAC specificity and kinase off-targeting by purine-benzohydroxamate anti-hematological tumor agents

Karoline B. Waitman, Larissa C. de Almeida, Marina C. Primi, Jorge A. E. G. Carlos, Claudia Ruiz, Thales Kronenberger, Stefan Laufer, Marcia Ines Goettert, Antti Poso, Sandra V. Vassiliades, Vinicius A. M. de Souza, Monica F. Z. J. Toledo, Neuza M. A. Hassimotto, Michael D. Cameron, Thomas D. Bannister, Leticia Costa-Lotufo, Joa o A. Machado-Neto, Mauricio T. Tavares, Roberto Parise-Filho

Summary: A series of hybrid inhibitors combining pharmacophores of known kinase inhibitors and benzohydroxamate HDAC inhibitors were synthesized and evaluated for their anticancer activity and pharmacokinetic properties. Compounds 4d-f exhibited promising cytotoxicity against hematological cells and moderate activity against solid tumor models. Compound 4d showed potent inhibition of multiple kinase targets and had stable interactions with HDAC and members of the JAK family. These compounds showed selective cytotoxicity with minimal effects on non-tumorigenic cells and favorable pharmacokinetic profiles.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2024)

Article Chemistry, Medicinal

Unexpected rearrangement of ivermectin in the synthesis of new derivatives with trypanocidal and antiplasmodial activities

Michal Sulik, Diana Fontinha, Dietmar Steverding, Szymon Sobczak, Michal Antoszczak, Miguel Prudencio, Adam Huczynski

Summary: This study describes the synthesis of the first-in-class ivermectin derivatives obtained through derivatization of the C13 position, along with the unexpected rearrangement of the macrolide ring. These derivatives show potential for antiparasitic activity and are important for the development of new antiparasitic agents.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2024)

Article Chemistry, Medicinal

Novel ligustilide derivatives target quorum sensing system LasR/LasB and relieve inflammatory response against Pseudomonas aeruginosa infection

Jun Liu, Qiu-Xian Chen, Wen-Fu Wu, Dong Wang, Si -Yu Zhao, Jia-Hao Li, Yi-Qun Chang, Shao-Gao Zeng, Jia-Yi Hu, Yu-Jie Li, Jia-Xin Du, Shu-Meng Jiao, Hai-Chuan Xiao, Qiang Zhang, Jun Xu, Jian-Fu Zhao, Hai -Bo Zhou, Yong-Heng Wang, Jian Zou, Ping-Hua Sun

Summary: A new anti-infective drug strategy has been discovered to attenuate virulence and modulate inflammation caused by drug-resistant Pseudomonas aeruginosa infections. Compound 5f inhibits biofilm formation, macrophage migration, and inflammatory response induced by P. aeruginosa, showing potential as a novel candidate against drug-resistant infections.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2024)

Article Chemistry, Medicinal

Design and synthesis of pterostilbene derivatives bearing triazole moiety that might treat DSS-induced colitis in mice through modulation of NF-KB/ MAPK signaling pathways

Liuzeng Chen, Ke Wang, Lingyun Wang, Wei Wang, Lifan Wang, Jia Li, Xiaohan Liu, Mengya Wang, Banfeng Ruan

Summary: In this study, a series of novel anti-inflammatory compounds were designed and synthesized based on the natural product pterostilbene skeleton. Among them, compound 8 showed the highest activity and exhibited its effects through inhibition of pro-inflammatory cytokines by blocking the NF-KB/MAPK signaling pathway. Compound 8 also demonstrated a good relieving effect on acute colitis in mice and showed good safety in acute toxicity experiments.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2024)

Article Chemistry, Medicinal

Discovery of 4-(N-dithiobenzyl piperazine)-1,8-naphthalimide as a potent multi-target antitumor agent with good efficacy, limited toxicity, and low resistance

Si-Min Liang, Gui-Bin Liang, Hui-Ling Wang, Hong Jiang, Xian-Li Ma, Jian-Hua Wei, Ri-Zhen Huang, Ye Zhang

Summary: A series of novel multi-target antitumor agents were designed, synthesized, and evaluated. Some compounds exhibited significant antitumor activity and one compound showed excellent efficacy, limited toxicity, and low resistance. Further mechanism studies revealed that the compound exerted antitumor effects through multiple pathways.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2024)